Citadel Group
(ASX:CGL) has entered into an agreement to buy Charm Health International and its subsidiaries for $8.2 million to expand its e-health offerings.
The supplier of oncology systems says the deal will ensure real time access to patient information, across multiple locations and health care teams.
The purchase represents a multiple of 6 times its proforma EBITDA.
Additional payments will also be made for the acquisition, over performance. They will be staggered over the next two years following completion.
Shares in Citadel Group
(ASX:CGL) last traded flat at $5.45.
